Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
JANX | Janux Therapeutics, Inc. | Director | $137K | Jun 26, 2024 | ||
EFTR, EFTRW | eFFECTOR Therapeutics, Inc. | Chief Business Officer | Jun 20, 2022 | |||
NKGN, NKGNW | NKGen Biotech, Inc. | Director | Sep 29, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|